Effects of olprinone, a phosphodiesterase III inhibitor, on ischemic acute renal failure

International Journal of Urology

Volumn 14, Issue 3, 2007, Pages 219-225

  Anas, Chabouk ^a   Ozaki, Takenori ^a   Maruyama, Shoichi ^a   Yamamoto, Tokunori ^a   Zu Gotoh, Momoka ^a   Ono, Yoshinari ^a   Matsuo, Seiichi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute renal failure; Ischemia reperfusion; Olprinone; Renal microcirculation; Renal transplantation

Indexed keywords

INTERLEUKIN 8; LOPRINONE; PHOSPHODIESTERASE III INHIBITOR; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; ENDOSCOPE; EXPERIMENTAL STUDY; FLOW RATE; HISTOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY PARENCHYMA; KIDNEY TUBULE CELL; MACROPHAGE; MALE; MICROCIRCULATION; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION; SUPERNATANT;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; BLOOD FLOW VELOCITY; BLOOD UREA NITROGEN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HUMANS; IMIDAZOLES; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-8; KIDNEY FAILURE, ACUTE; KIDNEY TUBULES, PROXIMAL; MALE; MICROSCOPY, VIDEO; PHOSPHODIESTERASE INHIBITORS; PYRIDONES; RATS; RATS, SPRAGUE-DAWLEY; RENAL CIRCULATION; REPERFUSION INJURY; TREATMENT OUTCOME;

EID: 33947222994     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2007.01689.x     Document Type: Article

References (28)

1. Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J. Am. Soc. Nephrol. 2003; 14: 2199-210.
2. Myers BD, Moran SM. Hemodynamically mediated acute renal failure. N. Engl. J. Med. 1986; 314: 97-105.
3. Halloran PF, Batiuk TD, Goes NB et al. Strategies to improve the immunologic management of organ transplants. Clin. Transplant. 1995; 9: 227-36.
4. Troppmann C, Gillingham KJ, Benedetti E et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation 1995; 59: 962-8.
5. Kootstra G. The asystolic, or non-heartbeating, donor. Transplantation 1997; 63: 917-21.
6. Koo DD, Welsh KI, McLaren AJ et al. Cadaver versus living donor kidneys: impact of donor factors on antigen induction before transplantation. Kidney Int. 1999; 56: 1551-9.
7. Kotsch K, Francuski M, Pascher A et al. Improved long-term graft survival after HO-1 induction in brain-dead donors. Am. J. Transplant. 2006; 6: 477-86.
8. Lieberthal W, Levine JS. Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury. Am. J. Physiol. 1996; 271: F477-88.
9. Kloner RA, Przyklenk K, Whittaker P. Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues. Circulation 1989; 80: 1115-27.
10. Ramirez R, Chong T, Curran B et al. Role of endothelin-1 and cyclic nucleotides in ischemia/reperfusion-mediated microvascular leak. J. Trauma 2006; 60: 515-22.
11. Zager RA, Johnson AC, Hanson SY, Lund S. Ischemic proximal tubular injury primes mice to endotoxin-induced TNF-alpha generation and systemic release. Am. J. Physiol. Renal Physiol. 2005; 289: F289-97.
12. Koga S, Morris S, Ogawa S et al. TNF modulates endothelial properties by decreasing cAMP. Am. J. Physiol. 1995; 268: C1104-13.
13. Brodsky SV, Yamamoto T, Tada T et al. Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells. Am. J. Physiol. Renal Physiol. 2002; 282: F1140-9.
14. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N. Engl. J. Med. 1996; 334: 1448-60.
15. Mizushige K, Ueda T, Yukiiri K, Suzuki H. Olprinone: a phosphodiesterase III inhibitor with positive inotropic and vasodilator effects. Cardiovasc. Drug Rev. 2002; 20: 163-74.
16. Sanada S, Kitakaze M, Papst PJ et al. Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors: the role of protein kinase A and p38 mitogen-activated protein kinase. Circulation 2001; 104: 705-10.
17. Ueda T, Mizushige K, Yukiiri K et al. The cerebrovascular dilatation effects of olprinone, a phosphodiesterase III inhibitor, in comparison with acetazolamide - a pilot study. Clin. Neurol. Neurosurg. 2004; 106: 284-8.
18. Tajimi M, Ozaki H, Sato K, Karaki H. Effect of a novel inhibitor of cyclic AMP phosphodiesterase, E-1020, on cytosolic Ca++ level and contraction in vascular smooth muscle. Naunyn Schmiedebergs Arch. Pharmacol. 1991; 344: 602-10.
19. Okuda K, Kudo H, Ohishi K et al. Effects of olprinone on IL-6 and IL-10 production during and after cardiac surgery. Masui 1997; 46: 1580-4.
20. Kanda M, Yasuda S, Goto Y et al. Diuretic effect of phosphodiesterase inhibitors depends on baseline renal function in patients with congestive heart failure. Am. J. Cardiol. 1999; 15: 1274-7.
21. Sadiq A, Tamura N, Yoshida M et al. Possible contribution of acetylamrinone and its enhancing effects on platelet aggregation under shear stress conditions in the onset of thrombocytopenia in patients treated with amrinone. Thromb. Res. 2003; 111: 357-61.
22. Yamamoto T, Hayasi K, Tomura Y et al. Direct in vivo visualization of renal microcirculation by intravital CCD videomicroscopy. Exp. Nephrol. 2001; 9: 150-5.
23. Melnikov VY, Faubel S, Siegmund B et al. Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice. J. Clin. Invest. 2002; 110: 1083-91.
24. Rahman A, Anwar KN, Minhajuddin M et al. cAMP targeting of p38 MAP kinase inhibits thrombin-induced NF-kappaB activation and ICAM-1 expression in endothelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004; 287: L1017-24.
25. Aizawa T, Wei H, Miano JM et al. Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells. Circ. Res. 2003; 93: 406-13.
26. Tang S, Leung JC, Abe K et al. Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo. Clin. Invest. 2003; 111: 515-27.
27. Mizutani A, Murakami K, Okajima K et al. Olprinone reduces ischemia/reperfusion-induced acute renal injury in rats through enhancement of cAMP. Shock 2005; 3: 281-7.
28. Krejci V, Hiltebrand LB, Erni D, Sigurdsson GH. Endothelin receptor antagonist bosentan improves microcirculatory blood flow in splanchnic organs in septic shock. Crit. Care Med. 2003; 31: 203-10.